1 minute read

Andreea Iordache

Next Article
Jorge Batista

Jorge Batista

Could you introduce

My name is Andreea Iordache and I am a pharmacy graduate from Romania, living in Brussels for a bit over 2 years. I am also an EPSA Soft-Skills Trainer from 2019. I am passionate about the healthcare field and I enjoy being part of the small changes that will make a better and healthier life for everyone in the future. In my free time, I love drawing, travelling, discovering the hidden treasures of Brussels, reading books, or just spending time with my friends.

Advertisement

What is your academic background + engaging initiatives when you were a student?

I studied at the Faculty of Pharmacy in Bucharest, Romania, from where I graduated in 2020. Starting with my first year of studies, I was engaged as a volunteer in the local student association and I started joining the events organized by the national one, FASFR Romania. I was very passionate about research and lab work at that time and together with a friend of mine, we decided to participate in our first EPSA event in the spring of 2018 in Baarlo, The Netherlands, to present our research project during Science Day. The event was much more than we could ever imagine, so we attended almost every EPSA event organized ever since and made many friends across Europe. I then applied for the 14th EPSA TNT and became a Soft-Skills Trainer and then I became part of the EPSA Team, first as Educational Affairs Coordinator and then as Vice President of Education.

Could you please detail your position and missions at the moment? What were your previous work experiences?

At the moment, I am working as a Junior Manager of Science & Regulatory Affairs for Vaccines Europe, a specialized group within the European Federation of Pharmaceutical Industries and Associations (EFPIA) - the professional association representing the innovative pharmaceutical industry in Europe. Vaccines Europe aims to drive a sustainable and resilient vaccines environment in Europe, protecting people against infectious diseases at all stages of life.

In my daily activities, I am interacting with members from the 15 innovative and research-based vaccine companies that our association represents, working together on different topics in the area of Research & Development, Medical, Manufacturing and Supply, Regulatory Affairs, and health emergency preparedness and response. We organize regular working group meetings, issue position papers, answer public consultations, proactively represent industry views on key issues of common interest addressed at the EU level, and raise awareness about the value of vaccines and vaccination for society.

This article is from: